Shanghai Junshi Biosciences Co Ltd (688180) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.004x

Based on the latest financial reports, Shanghai Junshi Biosciences Co Ltd (688180) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.41 Million ≈ $-3.72 Million USD) by net assets (CN¥6.30 Billion ≈ $921.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Junshi Biosciences Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Shanghai Junshi Biosciences Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shanghai Junshi Biosciences Co Ltd (688180) total liabilities for a breakdown of total debt and financial obligations.

Shanghai Junshi Biosciences Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Junshi Biosciences Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TG Therapeutics Inc NASDAQ:TGTX	-0.038x
LegoChem Biosciences Inc KQ:141080	-0.022x
Sinotrans Ltd Class A SHG:601598	0.044x
Sinomach Heavy Equipment Group Co Ltd SHG:601399	-0.020x
KURITA WTR IND.UNSP.ADR 2 F:KWI0	N/A
LEG Immobilien SE XETRA:LEG	0.017x
Crocs Inc NASDAQ:CROX	0.176x
Persimmon Plc F:OHP	-0.040x

Annual Cash Flow Conversion Efficiency for Shanghai Junshi Biosciences Co Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Junshi Biosciences Co Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Shanghai Junshi Biosciences Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.95 Billion ≈ $870.71 Million	CN¥-1.44 Billion ≈ $-211.13 Million	-0.242x	+11.46%
2023-12-31	CN¥7.32 Billion ≈ $1.07 Billion	CN¥-2.00 Billion ≈ $-293.39 Million	-0.274x	-51.10%
2022-12-31	CN¥9.79 Billion ≈ $1.43 Billion	CN¥-1.78 Billion ≈ $-259.79 Million	-0.181x	-135.29%
2021-12-31	CN¥8.33 Billion ≈ $1.22 Billion	CN¥-641.90 Million ≈ $-93.93 Million	-0.077x	+69.98%
2020-12-31	CN¥5.84 Billion ≈ $854.76 Million	CN¥-1.50 Billion ≈ $-219.32 Million	-0.257x	+35.40%
2019-12-31	CN¥2.99 Billion ≈ $437.31 Million	CN¥-1.19 Billion ≈ $-173.70 Million	-0.397x	-158.27%
2018-12-31	CN¥3.32 Billion ≈ $485.99 Million	CN¥-510.76 Million ≈ $-74.74 Million	-0.154x	+50.40%
2017-12-31	CN¥1.12 Billion ≈ $163.79 Million	CN¥-347.08 Million ≈ $-50.79 Million	-0.310x	-88.62%
2016-12-31	CN¥1.13 Billion ≈ $164.86 Million	CN¥-185.21 Million ≈ $-27.10 Million	-0.164x	-23.10%
2015-12-31	CN¥614.22 Million ≈ $89.88 Million	CN¥-82.03 Million ≈ $-12.00 Million	-0.134x	-9.00%
2014-12-31	CN¥319.87 Million ≈ $46.81 Million	CN¥-39.19 Million ≈ $-5.73 Million	-0.123x	--

About Shanghai Junshi Biosciences Co Ltd

SHG:688180 China Biotechnology

Market Cap

$4.52 Billion

CN¥30.91 Billion CNY

Market Cap Rank

#3835 Global

#626 in China

Share Price

CN¥40.38

Change (1 day)

+0.20%

52-Week Range

CN¥28.43 - CN¥48.80

All Time High

CN¥151.00